Germany Probiotics Dietary Supplements Market Size, Share, By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, and Others), By End Use (Infants, Children, Adults, and Geriatric), Germany Probiotics Dietary Supplements Market Insights, Industry Trend, Forecasts to 2035

Industry: Food & Beverages

RELEASE DATE Dec 2025
REPORT ID SI16610
PAGES 268
REPORT FORMAT PathSoft

Germany Probiotics Dietary Supplements Market Insights Forecasts to 2035

Germany Probiotics Dietary Supplements Market Size 2024: 292.8 Million

Germany Probiotics Dietary Supplements Market Size 2035: 667.5 Million

Germany Probiotics Dietary Supplements Market CAGR 2024: 7.78%

Germany Probiotics Dietary Supplements Market Segments: By Form & By End Use

 

Germany Probiotics Dietary Supplements Market

Get more details on this report -

Request Free Sample PDF

Government research funding and widespread consumer awareness further boost interest in functional probiotics. Additionally, around 22% of Germans are aged 65 or older, increasing demand for digestive and immunity supporting supplements.

 

Bayer AG has expanded its probiotic offerings with chewable and daily-use variants, while Danone focuses on gut-brain axis benefits through research collaborations. Nestlé Health Science launched age-specific supplement formats, and Probi AB introduced clinically backed next-generation strains.

Germany Probiotics Dietary Supplements Market Report Coverage

Report CoverageDetails
Base Year:2023
Market Size in 2023:USD 292.8 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :7.78%
2035 Value Projection: USD 667.5 Million
Historical Data for:2020-2023
No. of Pages:268
Tables, Charts & Figures:119
Segments covered:By Form, By End Use
Companies covered:: BioGaia AB Class B, Amway Malaysia Holdings, Symrise AG, DuPont de Nemours Inc, Archer-Daniels Midland Co, Bayer AG, GSK PLC, Glanbia PLC, Others Key Players
Pitfalls & Challenges:Covid 19 Impact Challenges, Future, Growth and Analysis

Get more details on this report -

Request Free Sample PDF
 

Germany Probiotics Dietary Supplements Market Dynamics:

The Germany probiotics dietary supplements market is driven by rising health consciousness, growing focus on digestive and immune health, an aging population, increasing preventive healthcare adoption, and higher consumer preference for natural, science-backed dietary supplements. Expanding awareness through media and healthcare professional’s further supports market growth.

 

The Germany probiotics dietary supplements market faces restraints from high product costs, stringent regulatory requirements, limited consumer awareness about strain-specific benefits, potential side effects, and intense competition from alternative functional foods and beverages.

 

The Germany probiotics dietary supplements market offers opportunities through growing demand for personalized and age-specific formulations, innovations in clinically validated probiotic strains, expansion of e-commerce and direct-to-consumer channels, and increasing interest in gut-brain health, immunity support, and natural, clean-label supplement products.

 

Market Segmentation

The Germany probiotics dietary supplements market share is classified into by form and end use.

 

By Form:

The tablets & softgels segment held the largest share in 2024, as these formats remain widely accepted and convenient for consumers seeking stable, reliable daily dosing of probiotic strains.

 

By End Use:

The adults segment held the largest share in 2024, driven by increasing health consciousness, preventive healthcare focus, and demand for digestive and immunity support among the adult population.

 

Competitive Landscape & Strategic Insights:

Decision Advisors presents a concise yet insightful competitive analysis of the Germany probiotics dietary supplements market, evaluating leading players based on product offerings, strategic initiatives, market presence, and competitive strengths. The report highlights recent innovations, partnerships, and End Use trends particularly cans providing a clear view of competitive dynamics and market positioning.

 

Top Key Companies in Germany Probiotics Dietary Supplements Market

  • BioGaia AB Class B
  • Amway Malaysia Holdings
  • Symrise AG
  • DuPont de Nemours Inc
  • Archer-Daniels Midland Co
  • Bayer AG
  • GSK PLC
  • Glanbia PLC

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Germany probiotics dietary supplements market based on the below-mentioned segments:

 

Germany Probiotics Dietary Supplements Market, By Form

  • Chewables & Gummies
  • Capsules
  • Powders
  • Tablets & Softgels
  • Others

 

Germany Probiotics Dietary Supplements Market, By End Use

  • Infants
  • Children
  • Adults
  • Geriatric

Frequently Asked Questions (FAQ)

  • Q: What is the Germany probiotics dietary supplements market size?
    A: Germany probiotics dietary supplements Market is expected to grow from USD 292.8 Million in 2024 to USD 667.5 Million by 2035, growing at a CAGR of 7.78% during the forecast period 2025-2035.
  • Q: What are the key growth drivers of the market?
    A: Expanding awareness through media and healthcare professional’s further supports market growth.
  • Q: What factors restrain the Germany probiotics dietary supplements market?
    A: The Germany probiotics dietary supplements market faces restraints from high product costs, stringent regulatory requirements, limited consumer awareness about strain-specific benefits.
  • Q: How is the market segmented by form?
    A: The market is segmented into chewables & gummies, capsules, powders, tablets & softgels, and others
  • Q: Who are the key players in the Germany probiotics dietary supplements market?
    A: Key companies include BioGaia AB Class B, Amway Malaysia Holdings, Symrise AG, DuPont de Nemours Inc, Archer-Daniels Midland Co, Bayer AG, GSK PLC, and Glanbia PLC.
  • Q: Who are the target audiences for this market report?
    A: The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies